Login

Financial Snapshot

Revenue
TTM
$539.6M
Gross Margin
TTM
74.77%
Net Income
TTM
-$55.35M
Current Assets
2025 Q4
$738.6M
Current Liabilities
2025 Q4
$247.0M
Current Ratio
2025 Q4
299.05%
Total Assets
2025 Q4
$820.4M
Total Liabilities
2025 Q4
$285.1M
Book Value
2025 Q4
535.3M
Cash
2025 Q4
$478.4M
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $91.824 Million

About Burning Rock Biotech Ltd

Burning Rock Biotech Ltd. engages in the investment of medical fields. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.

Industry: Services-Medical Laboratories Peers: Connect Biopharma Holdings Ltd Genetron Holdings Ltd Gracell Biotechnologies Inc. NovaBridge Biosciences Sinovac Biotech Ltd

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support